EA
PFE icon

Ellsworth Advisors’s Pfizer PFE Stock Holding History

Ellsworth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-105,067
Closed -$3.02M – 194
2023
Q4 		$3.02M Buy
105,067
+4,455
+4% +$135K 0.96% 44
2023
Q3 		$3.14M Buy
100,612
+1,981
+2% +$70.1K 1.11% 43
2023
Q2 		$3.62M Buy
98,631
+4,697
+5% +$183K 1.25% 40
2023
Q1 		$3.83M Sell
93,934
-1,417
-1% -$61.2K 1.35% 32
2022
Q4 		$4.29M Buy
95,351
+7,985
+9% +$383K 1.61% 13
2022
Q3 		$3.82M Buy
87,366
+3,195
+4% +$155K 1.64% 15
2022
Q2 		$4.41M Buy
84,171
+2,379
+3% +$121K 1.78% 10
2022
Q1 		$4.07M Buy
81,792
+12,400
+18% +$643K 1.44% 24
2021
Q4 		$4.1M Buy
69,392
+10,868
+19% +$538K 1.52% 15
2021
Q3 		$2.52M Buy
58,524
+14,740
+34% +$653K 1.15% 38
2021
Q2 		$1.72M Buy
43,784
+7,298
+20% +$284K 0.84% 50
2021
Q1 		$1.32M Buy
36,486
+8,195
+29% +$291K 0.8% 52
2020
Q4 		$1.04M Buy
28,291
+3,648
+15% +$134K 0.75% 54
2020
Q3 		$858K Sell
24,643
-173
-0.7% -$6.07K 0.86% 50
2020
Q2 		$770K Buy
+24,816
New +$843K 0.84% 49

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ellsworth Advisors's PFE Position: Q1 2024 in Review

Ellsworth Advisors sold out of Pfizer (PFE) in Q1 2024, closing a stake of 105,067 shares — an estimated $3.02M sold.

Ellsworth Advisors first reported a position in PFE in Q2 2020 and held it in 15 quarters. The position peaked at $4.41M in Q2 2022. 2,882 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Ellsworth Advisors reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Ellsworth Advisors sold 105,067 Pfizer shares in Q1 2024, an estimated $3.02M.
  • Ellsworth Advisors first reported a position in Pfizer in Q2 2020 and held it in 15 quarters.
  • Ellsworth Advisors's Pfizer position peaked at $4.41M in Q2 2022.
  • 2,882 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Ellsworth Advisors's 13F filing for Q1 2024, filed 15 Apr 2024.